Introduction
As part of the current Editorial Team's ongoing commitment to develop the impact and scope of the Journal, 1 we regularly analyse the material published in Cardiovascular Research and carefully assess how these have been received by the scientific community. This helps us to develop future directions of the Journal. Such analysis should be viewed in the context of continuity from the previous Editorial Office. 2 Here, we present a brief analysis of the recent 2017 impact factor (IF) release followed by an overview of hot topics that attracted strong interest from our readers from papers published in 2016 to 2017. 3 
Impact of Cardiovascular Research papers published in 2016 and 2017
Overall, 225 original articles and 62 reviews were published in Cardiovascular Research between 2016 and 2017; 28 of which were review articles featured in specialized spotlight issues. These articles have had an excellent level of visibility attracting, in total, 2705 citations in this short period. Original articles and reviews from 2016 to 2017 had an average of 8.6 citations per article. In addition, almost 20% of these papers (42/225) have attracted 15 or more citations. Of the top 50 cited articles, encouragingly, the majority (58%) are original articles. This underlines the strong reputation of Cardiovascular Research as the place to publish cutting-edge, high impact novel discoveries in cardiovascular science.
Editors' Choice articles attract higher citations
The previous Editorial team undertook research to determine whether an association existed between articles selected for Editors' Choice and the number of citations. Previous data showed that Editors' Choice articles have consistently aligned with a higher number of citations since 2014. Analysis of articles from 2016 to 2017 agree with the previous results; Editors' Choice articles attracted an average of 11.73 ± 0.97 citations relative to 6.03 ± 0.49 in those articles that were not selected ( Figure 2 ). There is, of course, potential bias that the Editorial Team will highlight the highest quality papers that would attract higher citations regardless. In addition, a paper selected as Editor's Choice may influence the reader to cite it. On the other hand, Editor's Choice articles are also freely available, and this could increase their visibility and number of citations. Definitive evidence as to whether open access papers receive a citation advantage over papers that are not freely available is an active area of research, yet, without a definitive conclusion.
Hot topics in Cardiovascular Research
We assessed the top papers by citations published in Cardiovascular Research between 2016 and 2017 to identify 'hot topics' that attracted high visibility. This selection of articles covered many aspects of both cardiac and vascular biology and disease; including some papers examining co-morbidities such as obesity [4] [5] [6] [7] and diabetes. [8] [9] [10] [11] This reflects the broad spectrum of high quality original science published by the Journal. [25] [26] [27] [28] as players in cardiac hypertrophy and heart failure. In addition to mechanistic studies, articles that have evaluated the potential of circulating noncoding RNAs such as miRNAs 29 and circular RNA 30 as biomarkers have received a lot of attention from readers. 31 
Translational studies using patient-derived cells receive award-winning recognition
Translational studies that reported mechanistic discoveries using cells derived from patients were among the top 20% of the most highly cited manuscripts. [32] [33] [34] [35] One of these papers 
Atherosclerosis and lipid biology dominates the vascular biology sub-category
Papers that covered aspects of vascular biology and pathophysiology composed approximately one-third of the top cited items. Within this category, manuscripts that focussed on atherosclerosis and lipid biology made up 40%. There was a clear trend for articles focussing on the role of immune cells in the establishment and maintenance of the atherosclerotic plaque. [36] [37] [38] [39] [40] From a translational perspective, the lessons learned for basic scientists from recent cardiovascular inflammation reduction clinical trials were nicely summarized in a review article. 41 There were also two original articles that highlighted the protective role of the adipokine, Omentin-1, in artherogenesis. 42, 43 The Journal published papers that provided novel insights on existing therapeutic targets for targeting atherosclerosis such as PCSK9 44, 45 and emerging strategies at a preclinical stage of development. 46, 47 The other papers within the vascular category covered a broad range of specialities such as aneurysms, 48 angiogenesis, 49 [95] [96] [97] [98] [99] [100] [101] [102] were approximately equally represented. Atrial fibrillation was also a key topic, having been featured in a Spotlight Issue in 2016. 103 Articles from more niche fields such as congenital heart disease 104, 105 and valvular disease 106 were also present in the top cited papers.
The Journal featured a Spotlight Issue on Metabolic Cardiomyopathies 107, 108 in response to the exciting findings of recent clinical trials, which have shown that drugs that affect metabolism may also have benefit for heart failure patients. In addition, several interesting original articles published in Cardiovascular Research have explored the role of mitochondria in cardioprotection, 109 heart failure, 110 and myocardial infarction. 111 
Conclusions
The analysis presented here of the most highly cited papers in Cardiovascular Research from 2016 and 2017 highlights the broad spectrum of research covered by the Journal and underlines its reputation as the place to publish and read the highest quality basic and translational cardiovascular science.
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